<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34303705</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>297</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Development of a specific live-cell assay for native autophagic flux.</ArticleTitle><Pagination><StartPage>101003</StartPage><MedlinePgn>101003</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101003</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbc.2021.101003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(21)00805-X</ELocationID><Abstract><AbstractText>Autophagy is an evolutionarily conserved pathway mediating the breakdown of cellular proteins and organelles. Emphasizing its pivotal nature, autophagy dysfunction contributes to many diseases; nevertheless, development of effective autophagy modulating drugs is hampered by fundamental deficiencies in available methods for measuring autophagic activity or flux. To overcome these limitations, we introduced the photoconvertible protein Dendra2 into the MAP1LC3B locus of human cells via CRISPR/Cas9 genome editing, enabling accurate and sensitive assessments of autophagy in living cells by optical pulse labeling. We used this assay to perform high-throughput drug screens of four chemical libraries comprising over 30,000 diverse compounds, identifying several clinically relevant drugs and novel autophagy modulators. A select series of candidate compounds also modulated autophagy flux in human motor neurons modified by CRISPR/Cas9 to express GFP-labeled LC3. Using automated microscopy, we tested the therapeutic potential of autophagy induction in several distinct neuronal models of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). In doing so, we found that autophagy induction exhibited discordant effects, improving survival in disease models involving the RNA binding protein TDP-43, while exacerbating toxicity in neurons expressing mutant forms of UBQLN2 and C9ORF72 associated with familial ALS/FTD. These studies confirm the utility of the Dendra2-LC3 assay, while illustrating the contradictory effects of autophagy induction in different ALS/FTD subtypes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Safren</LastName><ForeName>Nathaniel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tank</LastName><ForeName>Elizabeth M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Ahmed M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chua</LastName><ForeName>Jason P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santoro</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Chemical Genomics, Life Sciences Institute, University of Michigan, Ann Arbor Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barmada</LastName><ForeName>Sami J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor Michigan, USA. Electronic address: sbarmada@umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG053760</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS097542</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007863</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072931</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS113943</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C583169">Dendra2 protein, Dendronephthya</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008164">Luminescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C502070">MAP1LC3B protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405662">UBQLN2 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Biol Chem. 2022 Jan;298(1):101437</RefSource><PMID Version="1">34801556</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004354" MajorTopicYN="N">Drug Screening Assays, Antitumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057166" MajorTopicYN="N">High-Throughput Screening Assays</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008164" MajorTopicYN="N">Luminescent Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">high-content</Keyword><Keyword MajorTopicYN="N">high-throughput</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">photoconvertible</Keyword><Keyword MajorTopicYN="N">repurposing</Keyword><Keyword MajorTopicYN="N">screen</Keyword><Keyword MajorTopicYN="N">stem cell</Keyword></KeywordList><CoiStatement>Conflict of interest Nathaniel Safren, Elizabeth M. Tank, and Sami J. Barmada are coapplicants on a patent application for an assay probing mammalian autophagy (US Pat Appl 16/288802).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>25</Day><Hour>20</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34303705</ArticleId><ArticleId IdType="pmc">PMC8368035</ArticleId><ArticleId IdType="doi">10.1016/j.jbc.2021.101003</ArticleId><ArticleId IdType="pii">S0021-9258(21)00805-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290:1717&#x2013;1721.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2732363</ArticleId><ArticleId IdType="pubmed">11099404</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatica D., Lahiri V., Klionsky D.J. Cargo recognition and degradation by selective autophagy. Nat. Cell Biol. 2018;20:233&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6028034</ArticleId><ArticleId IdType="pubmed">29476151</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky D.J., Abdelmohsen K., Abe A., Abedin M.J., Abeliovich H., Acevedo Arozena A., Adachi H., Adams C.M., Adams P.D., Adeli K., Adhihetty P.J., Adler S.G., Agam G., Agarwal R., Aghi M.K. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Autophagy. 2016;12:1&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835977</ArticleId><ArticleId IdType="pubmed">26799652</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu X., Yu J., Bhagat G., Furuya N., Hibshoosh H., Troxel A., Rosen J., Eskelinen E.L., Mizushima N., Ohsumi Y., Cattoretti G., Levine B. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J.&#xa0;Clin. Invest. 2003;112:1809&#x2013;1820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC297002</ArticleId><ArticleId IdType="pubmed">14638851</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue Z., Jin S., Yang C., Levine A.J., Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. U. S. A. 2003;100:15077&#x2013;15082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC299911</ArticleId><ArticleId IdType="pubmed">14657337</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M., Waguri S., Ueno T., Iwata J., Murata S., Tanida I., Ezaki J., Mizushima N., Ohsumi Y., Uchiyama Y., Kominami E., Tanaka K., Chiba T. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J.&#xa0;Cell Biol. 2005;169:425&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2171928</ArticleId><ArticleId IdType="pubmed">15866887</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L., Bravo-San Pedro J.M., Levine B., Green D.R., Kroemer G. Pharmacological modulation of autophagy: Therapeutic potential and persisting obstacles. Nat. Rev. Drug Discov. 2017;16:487&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5713640</ArticleId><ArticleId IdType="pubmed">28529316</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Tortola L., Perlot T., Wirnsberger G., Novatchkova M., Nitsch R., Sykacek P., Frank L., Schramek D., Komnenovic V., Sigl V., Aumayr K., Schmauss G., Fellner N., Handschuh S. A&#xa0;dual role for autophagy in a murine model of lung cancer. Nat. Commun. 2014;5:3056.</Citation><ArticleIdList><ArticleId IdType="pubmed">24445999</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeldt M.T., O'Prey J., Morton J.P., Nixon C., MacKay G., Mrowinska A., Au A., Rai T.S., Zheng L., Ridgway R., Adams P.D., Anderson K.I., Gottlieb E., Sansom O.J., Ryan K.M. p53 status determines the role of autophagy in pancreatic tumour development. Nature. 2013;504:296&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">24305049</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzi L., Bravo-San Pedro J.M., Demaria S., Formenti S.C., Kroemer G. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nat. Rev. Clin. Oncol. 2017;14:247&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">27845767</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J.Y., Xia B., White E. Autophagy-mediated tumor promotion. Cell. 2013;155:1216&#x2013;1219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3987898</ArticleId><ArticleId IdType="pubmed">24315093</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M., Wang Q.J., Holstein G.R., Friedrich V.L., Iwata J., Kominami E., Chait B.T., Tanaka K., Yue Z. Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc. Natl. Acad. Sci. U. S. A. 2007;104:14489&#x2013;14494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1964831</ArticleId><ArticleId IdType="pubmed">17726112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., Mizushima N. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;441:885&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pubmed">16625204</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo J.H., Wang B., Frankel E., Ge L., Xu L., Iyengar R., Li-Harms X., Wright C., Shaw T.I., Lindsten T., Green D.R., Peng J., Hendershot L.M., Kilic F., Sze J.Y. The noncanonical role of ULK/ATG1 in ER-to-Golgi trafficking is essential for cellular homeostasis. Mol. Cell. 2016;62:491&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4993601</ArticleId><ArticleId IdType="pubmed">27203176</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C.C., Wang C., Peng X., Gan B., Guan J.L. Neural-specific deletion of FIP200 leads to cerebellar degeneration caused by increased neuronal death and axon degeneration. J.&#xa0;Biol. Chem. 2010;285:3499&#x2013;3509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2823459</ArticleId><ArticleId IdType="pubmed">19940130</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama J., Miura E., Mizushima N., Watanabe M., Yuzaki M. Aberrant membranes and double-membrane structures accumulate in the axons of Atg5-null Purkinje cells before neuronal death. Autophagy. 2007;3:591&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pubmed">17912025</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies F.M., Fleming A., Caricasole A., Bento C.F., Andrews S.P., Ashkenazi A., F&#xfc;llgrabe J., Jackson A., Jimenez Sanchez M., Karabiyik C., Licitra F., Lopez Ramirez A., Pavel M., Puri C., Renna M. Autophagy and neurodegeneration: Pathogenic mechanisms and therapeutic opportunities. Neuron. 2017;93:1015&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pubmed">28279350</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickford F., Masliah E., Britschgi M., Lucin K., Narasimhan R., Jaeger P.A., Small S., Spencer B., Rockenstein E., Levine B., Wyss-Coray T. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J.&#xa0;Clin. Invest. 2008;118:2190&#x2013;2199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2391284</ArticleId><ArticleId IdType="pubmed">18497889</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong E., Cuervo A.M. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 2010;13:805&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4038747</ArticleId><ArticleId IdType="pubmed">20581817</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez A., Heimbach A., Gr&#xfc;ndemann J., Stiller B., Hampshire D., Cid L.P., Goebel I., Mubaidin A.F., Wriekat A.L., Roeper J., Al-Din A., Hillmer A.M., Karsak M., Liss B., Woods C.G. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 2006;38:1184&#x2013;1191.</Citation><ArticleIdList><ArticleId IdType="pubmed">16964263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998;392:605&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">9560156</ArticleId></ArticleIdList></Reference><Reference><Citation>Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonz&#xe1;lez-Maldonado R., Deller T., Salvi S. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004;304:1158&#x2013;1160.</Citation><ArticleIdList><ArticleId IdType="pubmed">15087508</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanik S.A., Schultheiss C.E., Volpicelli-Daley L.A., Brunden K.R., Lee V.M. Lewy body-like &#x3b1;-synuclein aggregates resist degradation and impair macroautophagy. J.&#xa0;Biol. Chem. 2013;288:15194&#x2013;15210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3663539</ArticleId><ArticleId IdType="pubmed">23532841</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Vicente M., Talloczy Z., Wong E., Tang G., Koga H., Kaushik S., de Vries R., Arias E., Harris S., Sulzer D., Cuervo A.M. Cargo recognition failure is responsible for inefficient autophagy in Huntington&#x2019;s disease. Nat. Neurosci. 2010;13:567&#x2013;576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2860687</ArticleId><ArticleId IdType="pubmed">20383138</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazi A., Bento C.F., Ricketts T., Vicinanza M., Siddiqi F., Pavel M., Squitieri F., Hardenberg M.C., Imarisio S., Menzies F.M., Rubinsztein D.C. Polyglutamine tracts regulate beclin 1-dependent autophagy. Nature. 2017;545:108&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5420314</ArticleId><ArticleId IdType="pubmed">28445460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y.C., Holzbaur E.L. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J.&#xa0;Neurosci. 2014;34:1293&#x2013;1305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898289</ArticleId><ArticleId IdType="pubmed">24453320</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D.K.H., Thombre R., Wang J. Autophagy as a common pathway in amyotrophic lateral sclerosis. Neurosci. Lett. 2019;697:34&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6170747</ArticleId><ArticleId IdType="pubmed">29626651</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Bieniek K.F., Finch N., van de Vorst M., Baker M., Perkersen R., Brown P., Ravenscroft T., van Blitterswijk M., Nicholson A.M., DeTure M., Knopman D.S., Josephs K.A., Parisi J.E., Petersen R.C. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 2015;130:77&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4470809</ArticleId><ArticleId IdType="pubmed">25943890</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I., Van Mossevelde S., van der Zee J., Sieben A., Philtjens S., Heeman B., Engelborghs S., Vandenbulcke M., De Baets G., B&#xe4;umer V., Cuijt I., Van den Broeck M., Peeters K., Mattheijssens M., Rousseau F. Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology. 2015;85:2116&#x2013;2125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4691687</ArticleId><ArticleId IdType="pubmed">26581300</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I., Camuzat A., Guerreiro R., Bouya-Ahmed K., Bras J., Nicolas G., Gabelle A., Didic M., De Septenville A., Millecamps S., Lenglet T., Latouche M., Kabashi E., Campion D., Hannequin D. SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol. 2013;70:1403&#x2013;1410.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4199096</ArticleId><ArticleId IdType="pubmed">24042580</ArticleId></ArticleIdList></Reference><Reference><Citation>Synofzik M., Maetzler W., Grehl T., Prudlo J., Vom Hagen J.M., Haack T., Rebassoo P., Munz M., Sch&#xf6;ls L., Biskup S. Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype. Neurobiol. Aging. 2012;33:2949.e13&#x2013;2949.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">22892309</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E., Takeda T., Lebon V., Boill&#xe9;e S., Doukour&#xe9; B., Bataillon G., Sazdovitch V., Cazeneuve C., Meininger V., LeGuern E., Salachas F., Seilhean D., Millecamps S. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: Genetics and neuropathology. Acta Neuropathol. 2013;125:511&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pubmed">23417734</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., Komure O., Matsuura S., Kobatake K., Morimoto N., Abe K. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A. A&#xa0;hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Lasseigne B.N., Petrovski S., Sapp P.C., Dion P.A., Leblond C.S., Couthouis J., Lu Y.F., Wang Q., Krueger B.J., Ren Z., Keebler J., Han Y., Levy S.E., Boone B.E. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436&#x2013;1441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.-X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., Jiang H., Hirano M., Rampersaud E., Jansen G.H., Donkervoort S. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Florey O., Gammoh N., Kim S.E., Jiang X., Overholtzer M. V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation. Autophagy. 2015;11:88&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4502810</ArticleId><ArticleId IdType="pubmed">25484071</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoncu R., Bar-Peled L., Efeyan A., Wang S., Sancak Y., Sabatini D.M. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science. 2011;334:678&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3211112</ArticleId><ArticleId IdType="pubmed">22053050</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Serio A., Arjun A., Bilican B., Daub A., Ando D.M., Tsvetkov A., Pleiss M., Li X., Peisach D., Shaw C., Chandran S., Finkbeiner S. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat. Chem. Biol. 2014;10:677&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudakov D.M., Lukyanov S., Lukyanov K.A. Tracking intracellular protein movements using photoswitchable fluorescent proteins PS-CFP2 and Dendra2. Nat. Protoc. 2007;2:2024&#x2013;2032.</Citation><ArticleIdList><ArticleId IdType="pubmed">17703215</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer A.J., Lorin S., Blommaart E.F., Codogno P. Regulation of autophagy by amino acids and MTOR-dependent signal transduction. Amino Acids. 2015;47:2037&#x2013;2063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4580722</ArticleId><ArticleId IdType="pubmed">24880909</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfson R.L., Sabatini D.M. The dawn of the age of amino acid sensors for the mTORC1 pathway. Cell Metab. 2017;26:301&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5560103</ArticleId><ArticleId IdType="pubmed">28768171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocaturk N.M., Gozuacik D. Crosstalk between mammalian autophagy and the ubiquitin-proteasome system. Front. Cell Dev. Biol. 2018;6:128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6175981</ArticleId><ArticleId IdType="pubmed">30333975</ArticleId></ArticleIdList></Reference><Reference><Citation>Mali P., Yang L., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., Norville J.E., Church G.M. RNA-guided human genome engineering via Cas9. Science. 2013;339:823&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712628</ArticleId><ArticleId IdType="pubmed">23287722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran F.A., Hsu P.D., Lin C.Y., Gootenberg J.S., Konermann S., Trevino A.E., Scott D.A., Inoue A., Matoba S., Zhang Y., Zhang F. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell. 2013;154:1380&#x2013;1389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3856256</ArticleId><ArticleId IdType="pubmed">23992846</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoreen C.C., Kang S.A., Chang J.W., Liu Q., Zhang J., Gao Y., Reichling L.J., Sim T., Sabatini D.M., Gray N.S. An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J.&#xa0;Biol. Chem. 2009;284:8023&#x2013;8032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2658096</ArticleId><ArticleId IdType="pubmed">19150980</ArticleId></ArticleIdList></Reference><Reference><Citation>Maday S., Wallace K.E., Holzbaur E.L. Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J.&#xa0;Cell Biol. 2012;196:407&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3283992</ArticleId><ArticleId IdType="pubmed">22331844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N., Yamamoto A., Hatano M., Kobayashi Y., Kabeya Y., Suzuki K., Tokuhisa T., Ohsumi Y., Yoshimori T. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J.&#xa0;Cell Biol. 2001;152:657&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2195787</ArticleId><ArticleId IdType="pubmed">11266458</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Kang S.A., Thoreen C.C., Hur W., Wang J., Chang J.W., Markhard A., Zhang J., Sim T., Sabatini D.M., Gray N.S. Development of ATP-competitive mTOR inhibitors. Methods Mol. Biol. 2012;821:447&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3964610</ArticleId><ArticleId IdType="pubmed">22125084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetkov A.S., Miller J., Arrasate M., Wong J.S., Pleiss M.A., Finkbeiner S. A&#xa0;small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. Proc. Natl. Acad. Sci. U. S. A. 2010;107:16982&#x2013;16987.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2947884</ArticleId><ArticleId IdType="pubmed">20833817</ArticleId></ArticleIdList></Reference><Reference><Citation>Balgi A.D., Fonseca B.D., Donohue E., Tsang T.C., Lajoie P., Proud C.G., Nabi I.R., Roberge M. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One. 2009;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742736</ArticleId><ArticleId IdType="pubmed">19771169</ArticleId></ArticleIdList></Reference><Reference><Citation>Akar U., Ozpolat B., Mehta K., Fok J., Kondo Y., Lopez-Berestein G. Tissue transglutaminase inhibits autophagy in pancreatic cancer cells. Mol. Cancer Res. 2007;5:241&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">17374730</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe-Asano T., Kuma A., Mizushima N. Cycloheximide inhibits starvation-induced autophagy through mTORC1 activation. Biochem. Biophys. Res. Commun. 2014;445:334&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">24525133</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakeri A., Cicero A.F.G., Panahi Y., Mohajeri M., Sahebkar A. Curcumin: A naturally occurring autophagy modulator. J.&#xa0;Cell. Physiol. 2019;234:5643&#x2013;5654.</Citation><ArticleIdList><ArticleId IdType="pubmed">30239005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura S., Noda T., Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy. 2007;3:452&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">17534139</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Roy S., Lazar A.J., Wang W.L., McAuliffe J.C., Reynoso D., McMahon J., Taguchi T., Floris G., Debiec-Rychter M., Schoffski P., Trent J.A., Debnath J., Rubin B.P. Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST) Proc. Natl. Acad. Sci. U. S. A. 2010;107:14333&#x2013;14338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922542</ArticleId><ArticleId IdType="pubmed">20660757</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo S.Y., Castoreno A.B., Aldrich L.N., Lassen K.G., Goel G., Dan&#x10d;&#xed;k V., Kuballa P., Latorre I., Conway K.L., Sarkar S., Maetzel D., Jaenisch R., Clemons P.A., Schreiber S.L., Shamji A.F. Small-molecule enhancers of autophagy modulate cellular disease phenotypes suggested by human genetics. Proc. Natl. Acad. Sci. U. S. A. 2015;112:E4281&#x2013;E4287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4534235</ArticleId><ArticleId IdType="pubmed">26195741</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan S., Ahmed Z., Bradfute S.B., Arko-Mensah J., Mandell M.A., Won Choi S., Kimura T., Blanchet F., Waller A., Mudd M.H., Jiang S., Sklar L., Timmins G.S., Maphis N., Bhaskar K. Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential. Nat. Commun. 2015;6:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4624223</ArticleId><ArticleId IdType="pubmed">26503418</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerbini T., Funahashi R., Luo Y., Liu C., Park K., Rao M., Malik N., Zou J. Transcription activator-like effector nuclease (TALEN)-mediated CLYBL targeting enables enhanced transgene expression and one-step generation of dual reporter human induced pluripotent stem cell (iPSC) and neural stem cell (NSC) lines. PLoS One. 2015;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4294658</ArticleId><ArticleId IdType="pubmed">25587899</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandopulle M.S., Prestil R., Grunseich C., Wang C., Gan L., Ward M.E. Transcription factor&#x2013;mediated differentiation of human iPSCs into neurons. Curr. Protoc. Cell Biol. 2018;79</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993937</ArticleId><ArticleId IdType="pubmed">29924488</ArticleId></ArticleIdList></Reference><Reference><Citation>Maday S., Holzbaur E.L. Compartment-specific regulation of autophagy in primary neurons. J.&#xa0;Neurosci. 2016;36:5933&#x2013;5945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4887563</ArticleId><ArticleId IdType="pubmed">27251616</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans C.S., Holzbaur E.L.F. Autophagy and mitophagy in ALS. Neurobiol. Dis. 2019;122:35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6366665</ArticleId><ArticleId IdType="pubmed">29981842</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenzuela V., Nassif M., Hetz C. Unraveling the role of motoneuron autophagy in ALS. Autophagy. 2018;14:733&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5959335</ArticleId><ArticleId IdType="pubmed">29388464</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrasate M., Finkbeiner S. Automated microscope system for determining factors that predict neuronal fate. Proc. Natl. Acad. Sci. U. S. A. 2005;102:3840&#x2013;3845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC553329</ArticleId><ArticleId IdType="pubmed">15738408</ArticleId></ArticleIdList></Reference><Reference><Citation>Weskamp K., Safren N., Miguez R., Barmada S. Monitoring neuronal survival via longitudinal fluorescence microscopy. J.&#xa0;Vis. Exp. 2019 doi: 10.3791/59036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/59036</ArticleId><ArticleId IdType="pmc">PMC6594158</ArticleId><ArticleId IdType="pubmed">30735193</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik A.M., Miguez R.A., Li X., Ho Y.S., Feldman E.L., Barmada S.J. Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization. Elife. 2018;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6050042</ArticleId><ArticleId IdType="pubmed">30015619</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen E. Multivariate survival analysis using Cox&#x2019;s regression model. Hepatology. 1987;7:1346&#x2013;1358.</Citation><ArticleIdList><ArticleId IdType="pubmed">3679094</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.B., Lee V.M., Trojanowski J.Q. Gains or losses: Molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neurosci. 2012;13:38&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3285250</ArticleId><ArticleId IdType="pubmed">22127299</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Skibinski G., Korb E., Rao E.J., Wu J.Y., Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J.&#xa0;Neurosci. 2010;30:639&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores B.N., Li X., Malik A.M., Martinez J., Beg A.A., Barmada S.J. An intramolecular salt bridge linking TDP43 RNA binding, protein stability, and TDP43-dependent neurodegeneration. Cell Rep. 2019;27:1133&#x2013;1150.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499398</ArticleId><ArticleId IdType="pubmed">31018129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey L.M., Safren N., Pithadia A.S., Gerson J.E., Dulchavsky M., Fischer S., Patel R., Lantis G., Ashraf N., Kim J.H., Meliki A., Minakawa E.N., Barmada S.J., Ivanova M.I., Paulson H.L. Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assembly. Proc. Natl. Acad. Sci. U. S. A. 2018;115:E10495&#x2013;E10504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6217421</ArticleId><ArticleId IdType="pubmed">30333186</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R., Bett J.S., Keuss M.J., Solovyova A., McWilliams T.G., Johnson C., Sahu I., Varghese J., Wood N., Wightman M., Osborne G., Bates G.P., Glickman M.H., Trost M., Knebel A. UBQLN2 mediates autophagy-independent protein aggregate clearance by the proteasome. Cell. 2016;166:935&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorrie G.H., Fecto F., Radzicki D., Weiss C., Shi Y., Dong H., Zhai H., Fu R., Liu E., Li S., Arrat H., Bigio E.H., Disterhoft J.F., Martina M., Mugnaini E. Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2. Proc. Natl. Acad. Sci. U. S. A. 2014;111:14524&#x2013;14529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4209984</ArticleId><ArticleId IdType="pubmed">25246588</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J.J., Cai A., Greenslade J.E., Higgins N.R., Fan C., Le N.T.T., Tatman M., Whiteley A.M., Prado M.A., Dieriks B.V., Curtis M.A., Shaw C.E., Siddique T., Faull R.L.M., Scotter E.L. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function. Proc. Natl. Acad. Sci. U. S. A. 2020;117:15230&#x2013;15241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7334651</ArticleId><ArticleId IdType="pubmed">32513711</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;ent&#xfc;rk M., Lin G., Zuo Z., Mao D., Watson E., Mikos A.G., Bellen H.J. Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nat. Cell Biol. 2019;21:384&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6534127</ArticleId><ArticleId IdType="pubmed">30804504</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I., Van Langenhove T., van der Zee J., Sleegers K., Philtjens S., Kleinberger G., Janssens J., Bettens K., Van Cauwenberghe C., Pereson S., Engelborghs S., Sieben A., De Jonghe P., Vandenberghe R., Santens P. A&#xa0;C9orf72 promoter repeat expansion in a flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study. Lancet Neurol. 2012;11:54&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">22154785</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite A.J., B&#xe4;umer D., East S., Neal J., Morris H.R., Ansorge O., Blake D.J. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging. 2014;35:1779.e5&#x2013;1779.e13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3988882</ArticleId><ArticleId IdType="pubmed">24559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S., MacNair L., McGoldrick P., McKeever P.M., McLean J.R., Zhang M., Keith J., Zinman L., Rogaeva E., Robertson J. Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral sclerosis. Ann. Neurol. 2015;78:568&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pubmed">26174152</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C., Campanari M.L., Julie Corbier C., Gaucherot A., Kolb-Cheynel I., Oulad-Abdelghani M., Ruffenach F., Page A., Ciura S., Kabashi E., Charlet-Berguerand N. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 2016;35:1276&#x2013;1297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4910533</ArticleId><ArticleId IdType="pubmed">27103069</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M., Liang C., Swaminathan K., Herrlinger S., Lai F., Shiekhattar R., Chen J.F. A&#xa0;C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci. Adv. 2016;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5010369</ArticleId><ArticleId IdType="pubmed">27617292</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugolino J., Ji Y.J., Conchina K., Chu J., Nirujogi R.S., Pandey A., Brady N.R., Hamacher-Brady A., Wang J. Loss of C9orf72 enhances autophagic activity via deregulated mTOR and TFEB signaling. PLoS Genet. 2016;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5119725</ArticleId><ArticleId IdType="pubmed">27875531</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Lin S., Staats K.A., Li Y., Chang W.H., Hung S.T., Hendricks E., Linares G.R., Wang Y., Son E.Y., Wen X., Kisler K., Wilkinson B., Menendez L., Sugawara T. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin M., Pfister V., Gaucherot A., Ruffenach F., Negroni L., Sellier C., Charlet-Berguerand N. Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. EMBO J. 2020;39</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7024836</ArticleId><ArticleId IdType="pubmed">31930538</ArticleId></ArticleIdList></Reference><Reference><Citation>Amick J., Roczniak-Ferguson A., Ferguson S.M., Brill J. C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Mol. Biol. Cell. 2016;27:3040&#x2013;3051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5063613</ArticleId><ArticleId IdType="pubmed">27559131</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke J.G., Bogdanik L., Y&#xe1;&#xf1;ez A., Lall D., Wolf A.J., Muhammad A.K., Ho R., Carmona S., Vit J.P., Zarrow J., Kim K.J., Bell S., Harms M.B., Miller T.M., Dangler C.A. C9orf72 is required for proper macrophage and microglial function in mice. Science. 2016;351:1324&#x2013;1329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5120541</ArticleId><ArticleId IdType="pubmed">26989253</ArticleId></ArticleIdList></Reference><Reference><Citation>Boecker C.A., Olenick M.A., Gallagher E.R., Ward M.E., Holzbaur E.L.F. ToolBox: Live imaging of intracellular organelle transport in induced pluripotent stem cell-derived neurons. Traffic. 2020;21:138&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7061308</ArticleId><ArticleId IdType="pubmed">31603614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaizuka T., Morishita H., Hama Y., Tsukamoto S., Matsui T., Toyota Y., Kodama A., Ishihara T., Mizushima T., Mizushima N. An autophagic flux probe that releases an internal control. Mol. Cell. 2016;64:835&#x2013;849.</Citation><ArticleIdList><ArticleId IdType="pubmed">27818143</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguchi Y., Makanae K., Hasunuma T., Ishibashi Y., Kito K., Moriya H. Estimating the protein burden limit of yeast cells by measuring the expression limits of glycolytic proteins. Elife. 2018;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6086662</ArticleId><ArticleId IdType="pubmed">30095406</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriya H. Quantitative nature of overexpression experiments. Mol. Biol. Cell. 2015;26:3932&#x2013;3939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4710226</ArticleId><ArticleId IdType="pubmed">26543202</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognesi B., Lorenzo Gotor N., Dhar R., Cirillo D., Baldrighi M., Tartaglia G.G., Lehner B. A&#xa0;concentration-dependent liquid phase separation can cause toxicity upon increased protein expression. Cell Rep. 2016;16:222&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4929146</ArticleId><ArticleId IdType="pubmed">27320918</ArticleId></ArticleIdList></Reference><Reference><Citation>Leestemaker Y., de Jong A., Witting K.F., Penning R., Schuurman K., Rodenko B., Zaal E.A., van de Kooij B., Laufer S., Heck A.J.R., Borst J., Scheper W., Berkers C.R., Ovaa H. Proteasome activation by small molecules. Cell Chem. Biol. 2017;24:725&#x2013;736.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552582</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Machida Y., Niu S., Ikeda T., Jana N.R., Doi H., Kurosawa M., Nekooki M., Nukina N. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat. Med. 2004;10:148&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">14730359</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S., Davies J.E., Huang Z., Tunnacliffe A., Rubinsztein D.C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J.&#xa0;Biol. Chem. 2007;282:5641&#x2013;5652.</Citation><ArticleIdList><ArticleId IdType="pubmed">17182613</ArticleId></ArticleIdList></Reference><Reference><Citation>Alers S., L&#xf6;ffler A.S., Wesselborg S., Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: Cross talk, shortcuts, and feedbacks. Mol. Cell. Biol. 2012;32:2&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3255710</ArticleId><ArticleId IdType="pubmed">22025673</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W.Y., Xiao D., Wang L., Dong L.H., Yan Z.X., Shen Z.X., Chen S.J., Chen Y., Zhao W.L. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis. 2012;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3317343</ArticleId><ArticleId IdType="pubmed">22378068</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomic T., Botton T., Cerezo M., Robert G., Luciano F., Puissant A., Gounon P., Allegra M., Bertolotto C., Bereder J.M., Tartare-Deckert S., Bahadoran P., Auberger P., Ballotti R., Rocchi S. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis. 2011;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3186904</ArticleId><ArticleId IdType="pubmed">21881601</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Peng Y.-F., Ni H.-M., Li Y., Shi Y.-H., Ding W.-X., Fan J. Basal autophagy and feedback activation of Akt are associated with resistance to metformin-induced inhibition of hepatic tumor cell growth. PLoS One. 2015;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4482411</ArticleId><ArticleId IdType="pubmed">26111001</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S., Floto R.A., Berger Z., Imarisio S., Cordenier A., Pasco M., Cook L.J., Rubinsztein D.C. Lithium induces autophagy by inhibiting inositol monophosphatase. J.&#xa0;Cell Biol. 2005;170:1101&#x2013;1111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2171537</ArticleId><ArticleId IdType="pubmed">16186256</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Wang L., Wang R., Gao Y., Che H., Pan Y., Fu P. Evaluating the effectiveness of GTM-1, rapamycin, and carbamazepine on autophagy and Alzheimer disease. Med. Sci. Monit. 2017;23:801&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5321171</ArticleId><ArticleId IdType="pubmed">28193995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I.F., Guo B.S., Liu Y.C., Wu C.C., Yang C.H., Tsai K.J., Shen C.K. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl. Acad. Sci. U. S. A. 2012;109:15024&#x2013;15029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo K., Nassif M., Valenzuela V., Rojas F., Matus S., Mercado G., Court F.A., van Zundert B., Hetz C. Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy. 2013;9:1308&#x2013;1320.</Citation><ArticleIdList><ArticleId IdType="pubmed">23851366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S., Chigurupati S., Raymick J., Mann D., Bowyer J.F., Schmitt T., Beger R.D., Hanig J.P., Schmued L.C., Paule M.G. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model. Neurotoxicology. 2014;44:250&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">25064079</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon Y.S., Cho E.D., Jung Ahn W., Won Lee K., Lee S.J., Lee H.J. Is trehalose an autophagic inducer? Unraveling the roles of non-reducing disaccharides on autophagic flux and alpha-synuclein aggregation. Cell Death Dis. 2017;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5682667</ArticleId><ArticleId IdType="pubmed">28981090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H.J., Yoon Y.S., Lee S.J. Mechanism of neuroprotection by trehalose: Controversy surrounding autophagy induction. Cell Death Dis. 2018;9:712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6003909</ArticleId><ArticleId IdType="pubmed">29907758</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBosch B.J., Heitmeier M.R., Mayer A.L., Higgins C.B., Crowley J.R., Kraft T.E., Chi M., Newberry E.P., Chen Z., Finck B.N., Davidson N.O., Yarasheski K.E., Hruz P.W., Moley K.H. Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis. Sci. Signal. 2016;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4816640</ArticleId><ArticleId IdType="pubmed">26905426</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick N.D., Griffey C.J., Guarnieri P., Gerbino V., Wang X., Piersaint J.A., Tapia J.C., Rich M.M., Maniatis T. Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS. Proc. Natl. Acad. Sci. U. S. A. 2017;114:E8294&#x2013;E8303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Awad O., Sarkar C., Panicker L.M., Miller D., Zeng X., Sgambato J.A., Lipinski M.M., Feldman R.A. Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells. Hum. Mol. Genet. 2015;24:5775&#x2013;5788.</Citation><ArticleIdList><ArticleId IdType="pubmed">26220978</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox J.H., Connor T., Chopra V., Dorsey K., Kama J.A., Bleckmann D., Betschart C., Hoyer D., Frentzel S., Difiglia M., Paganetti P., Hersch S.M. The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington&#x2019;s disease. Mol. Neurodegener. 2010;5:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2908080</ArticleId><ArticleId IdType="pubmed">20569486</ArticleId></ArticleIdList></Reference><Reference><Citation>Subach O.M., Patterson G.H., Ting L.M., Wang Y., Condeelis J.S., Verkhusha V.V. A&#xa0;photoswitchable orange-to-far-red fluorescent protein, PSmOrange. Nat. Methods. 2011;8:771&#x2013;777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3164916</ArticleId><ArticleId IdType="pubmed">21804536</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuin C., Goodman A., Chernyshev V., Kamentsky L., Cimini B.A., Karhohs K.W., Doan M., Ding L., Rafelski S.M., Thirstrup D., Wiegraebe W., Singh S., Becker T., Caicedo J.C., Carpenter A.E. CellProfiler 3.0: Next-generation image processing for biology. PLoS Biol. 2018;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6029841</ArticleId><ArticleId IdType="pubmed">29969450</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold H.C., Jackson K.L., Arora A., Weskamp K., Tank E.M., Li X., Miguez R., Dayton R.D., Tamir S., Klein R.L., Barmada S.J. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci. Rep. 2018;8:4606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada S.J., Ju S., Arjun A., Batarse A., Archbold H.C., Peisach D., Li X., Zhang Y., Tank E.M., Qiu H., Huang E.J., Ringe D., Petsko G.A., Finkbeiner S. Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1. Proc. Natl. Acad. Sci. U. S. A. 2015;112:7821&#x2013;7826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4485101</ArticleId><ArticleId IdType="pubmed">26056265</ArticleId></ArticleIdList></Reference><Reference><Citation>Weskamp K., Tank E.M., Miguez R., McBride J.P., G&#xf3;mez N.B., White M., Lin Z., Gonzalez C.M., Serio A., Sreedharan J., Barmada S.J. Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS. J.&#xa0;Clin. Invest. 2020;130:1139&#x2013;1155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269575</ArticleId><ArticleId IdType="pubmed">31714900</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>